Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Herbal medicines for restlessness and anxiety

Clinical studies and empirical medicine confirm the effectiveness

    • News
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
  • 4 minute read

For the treatment of restlessness, insomnia and anxious mood, nature has provided us with a number of medicinal plants that can be taken as tinctures or finished preparations. The efficacy of various preparations has been clinically documented.

For the treatment of nervousness and sleep disorders we find in nature a number of medicinal plants, some of which are known for centuries and are used in appropriate situations (Tab.1). The difference between a sedative and sleep-inducing effect is really just a matter of dosage or when to take it. In the past, sedative and sleep-inducing medicinal plants were taken as teas or tinctures. Today, the pharmaceutical industry also provides tablets, dragées and capsules for these applications, some of which contain standardized extracts. Many combination preparations are also offered, the composition of which often has a scientifically justified meaning. Pharmacological studies have shown, for example, that the valerian hop extract Ze 91019 (Table 2) both promotes sleep readiness and improves the sleep-wake rhythm [1]. The efficacy of Ze 91019 has also been clinically confirmed [2]. The combination preparation Ze 185 contains, among other things, a plague root extract, which is also said to have an anti-anxiety effect.

For a very large number of patients who seek medical help for nervousness and insomnia, a tincture of the medicinal plants listed in Table 1 or a preparation as listed in Table 2 could help. Benzodiazepines or other strong-acting psychotropic drugs do not always have to be prescribed.

 

 

 

The kava ban

In the 1990s, herbal medicines based on extracts of kava, a West Ocean plant called Piper Methysticum, were registered and prescribed for anxiety. The feedback from patients was very positive and it was believed that a good substitute had been found for benzodiazepines with their great potential for dependence and other unpleasant side effects. Sales figures, especially of a kava preparation containing an acetonic kava extract, skyrocketed. But after the turn of the millennium, the crash occurred: between 1998 and 2000, reports of liver damage surfaced, all of which were linked to acetonic kava extract. Although the company concerned pointed out that some of the cases mentioned were poorly documented and could not be clearly attributed to its preparation, Swisssmedic issued a ban on the sale of the preparation in 2001. This ban was also imposed in other European countries, and in 2003 it was extended to all kava preparations, including alcoholic extracts. This was in contrast to the thousands of reports of incidents involving benzodiazepine preparations. In 2014, this kava ban was lifted again by a German court.

Lavender oil

After the kava ban, the treatment of anxiety with herbal medicines became quiet for a few years. However, preparations based on lavender oil from lavender (Lavandula officinalis) have been under discussion for some years (Fig. 1) . Lavender preparations have been used for a long time for calming purposes. The “lavender pillows” – bags filled with lavender flowers, which are placed next to the bed – have a long folk medicine tradition.

 

 

Studies

In recent years, several clinical studies have appeared documenting the efficacy of lavender oil preparations [1] for anxiety.
Woelk and Schläfke 2010: Woelk and Schläfke published a study in 2010 that compared efficacy versus lorazepam [3]. In this six-week study, patients with generalized anxiety disorder were treated with either a commercial preparation containing lavender oil or lorazepam. In both groups, the Hamilton Anxiety Scale improved from 25 at baseline (both groups) to 11.3 (lavender oil) and 11.6 (lorazempam).

Kasper et al. 2010: In the same year, another randomized, double-blind, placebo-controlled trial appeared [4]. 221 patients with anxious disorders were treated for ten weeks with either 80 mg daily of a lavender oil preparation or placebo. The benefit in the Hamilton anxiety scale was significantly better in the verum group compared with placebo (verum: -16.0; placebo: -9.5; p<0.01).

2013 review: Kasper also published a review in 2013 that evaluated five other studies in addition to the two discussed here [5]. This review also confirmed the effectiveness of lavender oil preparations in the treatment of anxiety disorders.

Summary

A number of medicinal plants are available for the treatment of restlessness and nervous insomnia, which can be taken as tinctures or standardized finished preparations. For the treatment of anxiety, preparations based on lavender oil have proven effective.

 *No lavender oil preparation is approved in Switzerland at the moment. The approval process for such a preparation is underway.

Literature: 

  1. Koetter U, Brattström A: A valerian-hops combination (Ze 91019) when used as a sleep inducing drug. Phytotherapy 2007; 3: 3-7.
  2. Koetter U, et al: A randomized, double blind, placebo controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Phytother Res 2007 Sep; 21(9): 847-851.
  3. Woelk H, Schläfke S: A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Phytomedicine 2010; 17(2): 94-99.
  4. Kasper S, et al: Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of subsyndromal anxiety disorder: a randomized, double-blind, placebo controlled trial. Int Clin Psychopharmacol 2010; 25(5): 277-287.
  5. Kasper S: An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review. Int J Psychiatry Clin Pract 2013 Nov; 17(Suppl. 1): 15-22.

HAUSARZT PRAXIS 2014; 9(11): 8

Autoren
  • Dr. pharm. Christoph Bachmann
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Anxiety
  • Hops
  • Lavender
  • Medicinal herbs
  • Melissa
  • Oats
  • Passionflower
  • Valerian
Previous Article
  • The knee pain by localization

Medical history and clinical examination are central

  • News
  • Orthopedics
  • RX
View Post
Next Article
  • Cohort study

What is the risk of tumor recurrence with arthritis therapy?

  • Geriatrics
  • Oncology
  • Rheumatology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 14 min
  • Patient-oriented recommendations for action

Effect of heat on diabetes technology

    • RX
    • CME continuing education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Prevention and health care
    • Studies
View Post
  • 19 min
  • Cardiovascular risk and obesity

Pathomechanisms, secondary prevention and treatment options

    • RX
    • Cardiology
    • CME continuing education
    • Endocrinology and Diabetology
    • Nutrition
    • Sports Medicine
    • Studies
    • Training with partner
View Post
  • 6 min
  • Ventricular arrhythmias

Indication for ICD or WCD?

    • RX
    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • Studies
View Post
  • 3 min
  • Early breast cancer

Overweight and obesity worsen the prognosis

    • Congress Reports
    • Gynecology
    • Oncology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 8 min
  • Psoriasis treatment with biologics

What are the latest trends?

    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • Rheumatology
    • RX
    • Studies
View Post
  • 4 min
  • Flu vaccination for older people

Benefit of the high-dose influenza vaccine

    • Congress Reports
    • General Internal Medicine
    • Geriatrics
    • Infectiology
    • RX
    • Studies
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 14 min
  • Artificial intelligence

Dr. ChatGPT: Large language models in everyday clinical practice

    • RX
    • Cases
    • CME continuing education
    • General Internal Medicine
    • Prevention and health care
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Pathomechanisms, secondary prevention and treatment options
  • 2
    Effect of heat on diabetes technology
  • 3
    Improved quality of care aims for satisfied patients
  • 4
    Dr. ChatGPT: Large language models in everyday clinical practice
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.

Notifications